JBC Oz Biosciences

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M405493200 on July 6, 2004

J. Biol. Chem., Vol. 279, Issue 37, 39175-39185, September 10, 2004
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
279/37/39175    most recent
M405493200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Le Boeuf, F.
Right arrow Articles by Huot, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Le Boeuf, F.
Right arrow Articles by Huot, J.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Regulation of Vascular Endothelial Growth Factor Receptor 2-mediated Phosphorylation of Focal Adhesion Kinase by Heat Shock Protein 90 and Src Kinase Activities*

Fabrice Le Boeuf{ddagger}, François Houle, and Jacques Huot§

From the Le Centre de recherche en cancérologie de l'Université Laval, L'Hôtel-Dieu de Québec, Québec G1R 2J6, Canada

Exposure of endothelial cells to vascular endothelial growth factor (VEGF) induced tyrosine phosphorylation of focal adhesion kinase (FAK) on site Tyr407, an effect that required the association of VEGF receptor 2 (VEGFR2) with HSP90. The association of VEGFR2 with HSP90 involved the last 130 amino acids of VEGFR2 and was blocked by geldanamycin, a specific inhibitor of HSP90. Moreover, geldanamycin inhibited the VEGF-induced activation of the small GTPase RhoA, which resulted in an inhibition of phosphorylation of FAK on site Tyr407. In this context, the inhibition of RhoA kinase (ROCK) with Y27632 or by expression of dominant negative forms of RhoA or ROCK impaired the VEGF-induced phosphorylation of Tyr407 within FAK. In contrast to phosphorylation of Tyr861, the phosphorylation of site Tyr407 was insensitive to Src kinase inhibition by 4-amino-5-(4-chlorophenyl)-7-(t-butyl) pyrazolo[3,4-d] pyrimidine (PP2). We also found that the recruitment of paxillin to FAK was inhibited by geldanamycin but not by PP2, whereas both geldanamycin and PP2 inhibited the recruitment of vinculin to FAK. In accordance, the recruitment of paxillin and vinculin to FAK was inhibited in cells that express the mutant FAK-Y407F, whereas the expression of the mutant Y861F inhibited the recruitment of paxillin but not of vinculin. Importantly, cell migration was abolished in cells in which the signal from the VEGFR2-HSP90 pathway was blocked by the expression of {Delta}130VEGFR2, a deletant of VEGFR2 that does not associate with HSP90. Our findings underscore for the first time the key role played by the VEGFR2-HSP90-RhoA-ROCK-FAK/Tyr407 pathway in transducing the VEGF signal that leads to the assembly of focal adhesions and endothelial cell migration.


Received for publication, May 17, 2004 , and in revised form, June 24, 2004.

* This work was supported by The Canadian Institutes for Health Research Grant MOP 15402. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

{ddagger} Held a studentship from "La Fondation de Transplantation d'Organes de France."

§ To whom correspondence should be addressed: Centre de recherche en cancérologie de l'Université Laval, L'Hôtel-Dieu de Québec, 9 rue McMahon, Québec G1R 2J6, Canada. Tel.: 418-525-4444 (ext. 15553); Fax: 418-691-5439; E-mail: Jacques.Huot{at}phc.ulaval.ca.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
A. Chatterjee, C. Snead, G. Yetik-Anacak, G. Antonova, J. Zeng, and J. D. Catravas
Heat shock protein 90 inhibitors attenuate LPS-induced endothelial hyperpermeability
Am J Physiol Lung Cell Mol Physiol, April 1, 2008; 294(4): L755 - L763.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
T. Yi, Z. Yi, S.-G. Cho, J. Luo, M. K. Pandey, B. B. Aggarwal, and M. Liu
Gambogic Acid Inhibits Angiogenesis and Prostate Tumor Growth by Suppressing Vascular Endothelial Growth Factor Receptor 2 Signaling
Cancer Res., March 15, 2008; 68(6): 1843 - 1850.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
M. Duval, F. Le B uf, J. Huot, and J.-P. Gratton
Src-mediated Phosphorylation of Hsp90 in Response to Vascular Endothelial Growth Factor (VEGF) Is Required for VEGF Receptor-2 Signaling to Endothelial NO Synthase
Mol. Biol. Cell, November 1, 2007; 18(11): 4659 - 4668.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
A. B. El-Remessy, M. Al-Shabrawey, D. H. Platt, M. Bartoli, M. A. Behzadian, N. Ghaly, N. Tsai, K. Motamed, and R. B. Caldwell
Peroxynitrite mediates VEGF's angiogenic signal and function via a nitration-independent mechanism in endothelial cells
FASEB J, August 1, 2007; 21(10): 2528 - 2539.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
L. Yin, K.-i. Morishige, T. Takahashi, K. Hashimoto, S. Ogata, S. Tsutsumi, K. Takata, T. Ohta, J. Kawagoe, K. Takahashi, et al.
Fasudil inhibits vascular endothelial growth factor-induced angiogenesis in vitro and in vivo
Mol. Cancer Ther., May 1, 2007; 6(5): 1517 - 1525.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Lim, H. Park, J. Jeon, I. Han, J. Kim, E.-H. Jho, and E.-S. Oh
Focal Adhesion Kinase Is Negatively Regulated by Phosphorylation at Tyrosine 407
J. Biol. Chem., April 6, 2007; 282(14): 10398 - 10404.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
L. Lamalice, F. Le Boeuf, and J. Huot
Endothelial Cell Migration During Angiogenesis
Circ. Res., March 30, 2007; 100(6): 782 - 794.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
W. Xu and L. Neckers
Targeting the Molecular Chaperone Heat Shock Protein 90 Provides a Multifaceted Effect on Diverse Cell Signaling Pathways of Cancer Cells
Clin. Cancer Res., March 15, 2007; 13(6): 1625 - 1629.
[Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Lamalice, F. Houle, and J. Huot
Phosphorylation of Tyr1214 within VEGFR-2 Triggers the Recruitment of Nck and Activation of Fyn Leading to SAPK2/p38 Activation and Endothelial Cell Migration in Response to VEGF
J. Biol. Chem., November 10, 2006; 281(45): 34009 - 34020.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
X. Q. Werdich and J. S. Penn
Specific Involvement of Src Family Kinase Activation in the Pathogenesis of Retinal Neovascularization
Invest. Ophthalmol. Vis. Sci., November 1, 2006; 47(11): 5047 - 5056.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
I. Mandeville, J. Aubin, M. LeBlanc, M. Lalancette-Hebert, M.-F. Janelle, G. M. Tremblay, and L. Jeannotte
Impact of the Loss of Hoxa5 Function on Lung Alveogenesis
Am. J. Pathol., October 1, 2006; 169(4): 1312 - 1327.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. Murtagh, H. Lu, and E. L. Schwartz
Taxotere-Induced Inhibition of Human Endothelial Cell Migration Is a Result of Heat Shock Protein 90 Degradation
Cancer Res., August 15, 2006; 66(16): 8192 - 8199.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
F. Le Boeuf, F. Houle, M. Sussman, and J. Huot
Phosphorylation of Focal Adhesion Kinase (FAK) on Ser732 Is Induced by Rho-dependent Kinase and Is Essential for Proline-rich Tyrosine Kinase-2-mediated Phosphorylation of FAK on Tyr407 in Response to Vascular Endothelial Growth Factor
Mol. Biol. Cell, August 1, 2006; 17(8): 3508 - 3520.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
H. Lu, J. Murtagh, and E. L. Schwartz
The Microtubule Binding Drug Laulimalide Inhibits Vascular Endothelial Growth Factor-Induced Human Endothelial Cell Migration and Is Synergistic when Combined with Docetaxel (Taxotere)
Mol. Pharmacol., April 1, 2006; 69(4): 1207 - 1215.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
S. Sanderson, M. Valenti, S. Gowan, L. Patterson, Z. Ahmad, P. Workman, and S. A. Eccles
Benzoquinone ansamycin heat shock protein 90 inhibitors modulate multiple functions required for tumor angiogenesis.
Mol. Cancer Ther., March 1, 2006; 5(3): 522 - 532.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
S. L. Cuvelier, S. Paul, N. Shariat, P. Colarusso, and K. D. Patel
Eosinophil adhesion under flow conditions activates mechanosensitive signaling pathways in human endothelial cells
J. Exp. Med., September 19, 2005; 202(6): 865 - 876.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2004 by the American Society for Biochemistry and Molecular Biology.